XULANE LOW Trademark

Trademark Overview


On Friday, October 27, 2023, a trademark application was filed for XULANE LOW with the United States Patent and Trademark Office. The USPTO has given the XULANE LOW trademark a serial number of 98243175. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 26, 2024. This trademark is owned by Mylan Pharmaceuticals Inc.. The XULANE LOW trademark is filed in the Pharmaceutical Products category with the following description:

Transdermal contraceptives

General Information


Serial Number98243175
Word MarkXULANE LOW
Filing DateFriday, October 27, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 26, 2024

Trademark Statements


Goods and ServicesTransdermal contraceptives
Disclaimer with Predetermined TextLOW

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 3, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMylan Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26506

Party NameMylan Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26506

Trademark Events


Event DateEvent Description
Tuesday, March 26, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2024PUBLISHED FOR OPPOSITION
Wednesday, March 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 6, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 20, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 20, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 16, 2024NON-FINAL ACTION E-MAILED
Friday, February 16, 2024NON-FINAL ACTION WRITTEN
Wednesday, February 7, 2024ASSIGNED TO EXAMINER
Friday, November 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 31, 2023NEW APPLICATION ENTERED

Related Keywords


xulane contraceptives transdermal